A phase II evaluation of bevacizumab in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group (GOG) study Meeting Abstract
| Authors: | Aghajanian, C.; Sill, M. W.; Darcy, K.; Greer, B.; McMeekin, D. S.; Rose, P. G.; Rotmensch, J.; Barnes, M. N.; Hanjani, P.; Leslie, K. |
| Abstract Title: | A phase II evaluation of bevacizumab in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group (GOG) study |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 284s |
| Language: | English |
| ACCESSION: | WOS:000276606600033 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.5531 |
| Notes: | Meeting Abstract: 5531 -- Source: Wos |
